Clinical Trials Logo

Tobacco Use clinical trials

View clinical trials related to Tobacco Use.

Filter by:

NCT ID: NCT03559751 Completed - Tobacco Use Clinical Trials

Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes

Start date: April 13, 2018
Phase: Phase 1
Study type: Interventional

This study is designed to evaluate the abuse liability of very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes

NCT ID: NCT03559725 Completed - Tobacco Use Clinical Trials

Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes

Start date: May 1, 2018
Phase: Phase 1
Study type: Interventional

This study is designed to evaluate the abuse liability of mentholated very low nicotine cigarettes compared to nicotine gum and usual brand cigarettes.

NCT ID: NCT03553992 Completed - Smoking Cessation Clinical Trials

An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers

POP-6
Start date: October 29, 2018
Phase: N/A
Study type: Interventional

The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexual or gender minorities (SGM), and use Facebook. Primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 months.

NCT ID: NCT03477435 Completed - Tobacco Use Clinical Trials

Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics

Start date: August 28, 2019
Phase: N/A
Study type: Interventional

The investigators propose a Type I hybrid effectiveness/implementation study to evaluate two population-based approaches for increasing use of Quitlines and text messaging at two VA sites. Specifically, the investigators will test the default bias, examining whether an opt-out approach to referral is more effective than an opt-in approach. The investigators will randomly assign teams to either an opt-out or opt-in approach to referring smokers to treatment. In the opt-out approach, the default is that everyone is referred to treatment unless they actively choose not to be. In the opt-in approach, people are offered treatment but must actively choose to enroll in it.

NCT ID: NCT03476837 Completed - Tobacco Use Clinical Trials

Reducing Tobacco Exposures Among African American Women and Children

FRESH
Start date: January 15, 2020
Phase: N/A
Study type: Interventional

Secondhand smoke exposure in the home can causes sudden infant death syndrome (SIDS), asthma, respiratory illnesses, and ear infections in children. In addition to cigarette smoke, exposure to other tobacco products can further compromise the safety of children in the home. This study aims to reduce the burden of multiple tobacco exposures, improve access to preventive care, and reduce the disproportionate risk for chronic diseases, including cancer, among African American women and children living in the Arkansas Delta region. Our central hypothesis is that messages delivered by a community health worker that aim to modify knowledge, attitudes, beliefs, and subjective norms may influence the perceived threat of tobacco exposures and provide cues for African American women caregivers to implement comprehensive smokefree policies to protect their children from the harms of tobacco and in-turn, influence their quitting.

NCT ID: NCT03463837 Completed - Tobacco Use Clinical Trials

Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers

Diamond
Start date: March 4, 2018
Phase: N/A
Study type: Interventional

The JUUL 5% Electronic Nicotine Delivery System (ENDS) is being studied as an alternative to combustible cigarette use. This study aims to find out how much nicotine is in the blood and urine of healthy adult subjects after using three JUUL 5% ENDS compared to smoking usual brands of combustible cigarettes and stopping smoking.

NCT ID: NCT03453385 Completed - Smoking Clinical Trials

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

CONNECT
Start date: May 24, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product. E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco. Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine. E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe. We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior. Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study. There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.

NCT ID: NCT03446170 Completed - Tobacco Use Clinical Trials

Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers

Start date: September 1, 2014
Phase: N/A
Study type: Interventional

The objective of this study is to examine whether cigarette packaging regulations including graphic health warning labels on cigarette packs and requiring plain, unbranded packaging reduce the appeal of cigarettes and prompt young adult smokers to quit.

NCT ID: NCT03379142 Completed - Tobacco Use Clinical Trials

Faith Based Pilot Intervention to Reduce Tobacco Use Among Somali Males

Start date: December 30, 2017
Phase: N/A
Study type: Interventional

1.1 In the last five years, representatives of WellShare International and the University of Minnesota have engaged a large community of Muslims of Somali descent in the Twin Cities of Minnesota in a community-academic research program to understand smoking and cessation behaviors. This followed research by WellShare International which discovered a smoking prevalence among Somali men of 44%, which is nearly three times that of the general population (14.4%) in Minnesota. More recently, pilot data from ecological momentary assessments (EMA) conducted by WellShare International and the University of Minnesota Program in Health Disparities Research before and during Ramadan, showed that the majority of smokers achieved spontaneous significant reductions in cigarettes smoked per day during Ramadan. Guided by the NIH Stage Based Intervention Development Model, this study aims to understand the processes underlying smoking reduction and cessation during Ramadan. The investigators plan to harness this knowledge and develop a culturally-tailored, faith-based smoking cessation intervention (Stage 1). The investigators also plan to assess the feasibility of the new culturally-tailored smoking cessation intervention by conducting a pilot study (Stage 2). The study aims are as follows: Aim 1: To develop a faith-based, community-informed innovative smoking cessation intervention for use with a Somali immigrant population in Minnesota: Aim 2: To assess the feasibility of a faith-based smoking cessation intervention delivered via a mobile phone during the Ramadan period: This pilot study will test a protocol for use of faith based text messages, as informed by the scholarly work of the Imams, Community Advisory Group (CAG) and focus groups conducted in Stage 1.

NCT ID: NCT03322501 Completed - Tobacco Use Clinical Trials

Pediatric Health Promotion Program

Start date: August 7, 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if an Ask, Advise, Connect (AAC) intervention model benefits tobacco control outcomes for pediatric primary care providers (pPCP's) and their young patients.